Treatment with moxifloxacin versus standard therapy for community-acquired pneumonia.
Solnick
Jay V
JV
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001372:Aza Compounds / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy; D024841:Fluoroquinolones; D006801:Humans; D000077266:Moxifloxacin; D011014:Pneumonia / Q000188:drug therapy*; D011804:Quinolines / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin